Home
Conditions
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Clinical trial condition

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Explore clinical trials studying Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative. Study availability and eligibility vary by location and protocol.

154 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative trial results

Completed

Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders

NCT02210858

Conditions: Accelerated Phase of Disease, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, +21 more
Locations: Stanford Cancer Institute Palo Alto, California, United States

University of Rochester Rochester, New York, United States

View Trial Details

Completed

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00445952

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
Locations: Institut Jules Bordet Brussels, Belgium

CHU de Grenoble - Hopital de la Tronche Grenoble, France

German Hodgkin's Lymphoma Study Group Cologne, Germany

Ospedale San Martino Genoa, Italy

View Trial Details

Completed

Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant

NCT00281814

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +63 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

NCT00964821

Conditions: Anemia, Anemia, Aplastic, Blast Crisis, +73 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

City of Hope Medical Group Pasadena, California, United States

View Trial Details

Completed

Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer

NCT00006239

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +20 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00245037

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +81 more
Locations: Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

NCT00691015

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +57 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

NCT00376922

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00118352

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +135 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

University of Torino Torino, Italy

View Trial Details

Completed

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

NCT00513474

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +72 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative trial results

Related conditions